The aim of this study is to investigate (1) whether expression of COX-2 and PPARγ is associated with ovarian carcinogenesis and progression of ovarian tumours and (2) whether COX-2 expression is controlled through ligand-mediated activation of PPARγ in ovarian carcinoma cells. This evidence concerns the gene PTGS2 and ovarian neoplasm.